Johannes Schetelig Selected Research

Johannes Schetelig Research Topics

Disease

36	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 09/2008
19	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2002
18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022 - 05/2007
16	Neoplasms (Cancer) 02/2022 - 03/2010
12	Leukemia 01/2022 - 11/2005
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2009
6	Infections 01/2020 - 11/2005
3	Disease Progression 01/2020 - 02/2015
3	Multiple Myeloma 01/2020 - 11/2016
3	Lymphoma (Lymphomas) 12/2019 - 10/2002
2	Bronchiolitis Obliterans Syndrome 01/2022 - 03/2002
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 11/2005
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 12/2020
2	COVID-19 04/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019 - 01/2018
2	Pathologic Complete Response 12/2019 - 11/2019
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2019 - 04/2004
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2019 - 01/2019
2	Iron Overload 05/2018 - 12/2012
2	Tumor Lysis Syndrome 01/2017 - 03/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2009
2	Residual Neoplasm 07/2013 - 11/2009
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2009 - 09/2008
1	Disseminated Intravascular Coagulation 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2021
1	Clostridium Infections 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Enterocolitis 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Cytomegalovirus Infections (Inclusion Disease) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Hyperuricemia 01/2017

Drug/Important Bio-Agent (IBA)

5	fludarabineIBA 01/2020 - 10/2002
4	idelalisibIBA 02/2022 - 12/2020
4	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 03/2002
4	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2019 - 07/2011
4	Alemtuzumab (Campath)FDA Link 10/2015 - 04/2004
3	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 09/2012
3	Peptides (Polypeptides)IBA 01/2021 - 06/2011
3	purineIBA 11/2019 - 12/2014
3	NucleophosminIBA 01/2018 - 03/2016
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 01/2009
2	Calcineurin InhibitorsIBA 01/2022 - 01/2009
2	EpitopesIBA 01/2021 - 02/2018
2	Minor Histocompatibility AntigensIBA 01/2021 - 04/2012
2	Busulfan (Busulfex)FDA Link 01/2020 - 03/2010
2	ibrutinibIBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 11/2016
2	venetoclaxIBA 01/2018 - 06/2016
2	Clofarabine (Clolar)FDA Link 12/2017 - 06/2016
2	rasburicase (Elitek)FDA Link 01/2017 - 03/2014
2	RheniumIBA 10/2015 - 03/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2012 - 03/2002
2	Cidofovir (Vistide)FDA Link 06/2007 - 01/2007
2	Foscarnet FDA LinkGeneric 06/2007 - 04/2004
1	trans-crotonin (CTN)IBA 01/2022
1	isocitric acid (isocitrate)IBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021
1	CPX-351IBA 10/2021
1	CC ChemokinesIBA 04/2021
1	plerixafor FDA Link 01/2021
1	Decitabine FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	treosulfanIBA 01/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2019
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	IronIBA 05/2018
1	ProteomeIBA 02/2018
1	serum P-component (CIt)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	Urate Oxidase (Uricase)IBA 01/2017
1	Hyaluronic Acid (Hyaluronan)IBA 11/2016
1	AntigensIBA 11/2016

Therapy/Procedure

26	Stem Cell Transplantation 02/2022 - 11/2003
21	Hematopoietic Stem Cell Transplantation 01/2022 - 11/2005
21	Cell Transplantation 01/2022 - 09/2008
16	Therapeutics 06/2022 - 04/2004
13	Transplantation 01/2021 - 09/2008
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2003
4	Salvage Therapy 01/2022 - 09/2008
4	Radioimmunotherapy 01/2020 - 03/2010
3	Homologous Transplantation 01/2019 - 03/2002
1	Blood Component Removal (Apheresis) 01/2021
1	Donor Selection 01/2020
1	Long-Term Care 01/2019
1	Immunotherapy 02/2018